To demonstrate that Robotic-Assisted partial nephrectomy is superior to Open partial nephrectomy in reducing the number of 30 day post-operative complications (Clavien-Dindo Type I-V) for patients with intermediate to high complexity kidney tumors.
Partial nephrectomy is the surgical removal of a kidney tumor while unaffected tissue remains intact so that the kidney function is maintained as far as possible. The more radical procedure would be the complete removal of the kidney, which is not examined in this trial. Surgery will be randomized either to an open technique involving a large incision or the robotic assisted technique with a few small incisions (keyhole surgery). With robotic assisted surgery the movements of the surgeon are translated into the movement of the instruments. It is not clear which of the two procedures, open or robotic assisted, has less complications. It is expected that these are different due to the different level of invasiveness and the level of direct access to the organ. This study aims to show that robotic assisted surgery results in less complications than open surgery.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
247
Application of the da Vinci surgical robot to assist the partial nephrectomy
Open surgery to conduct the partial nephrectomy
Dept. of Urology, University Hospital Tübingen
Tübingen, Germany, Germany
Department of Urology, University Hospital Düsseldorf
Düsseldorf, Germany
Department of Urology, Alfried Krupp Krankenhaus Rüttenscheid
Essen, Germany
30 day complications
Any complication that occurred within 30 days post surgery
Time frame: Day of surgery to 30th post operative day
Operative time
Timing of surgical steps in the OR
Time frame: Day of surgery
Ischemia time
Period in which the kidney has no blood supply
Time frame: Day of surgery
Surgical radicality conversions
Conversion from robotic to open, partial to radical
Time frame: Day of surgery
Intraoperative blood loss
Volume of blood loss during the surgical procedure
Time frame: Day of surgery
Pain assessment
Assessment of pain level via the Brief Pain Inventory (BPI)
Time frame: Baseline until Day 90
Pain Medication
Recording pain medication
Time frame: Baseline until Day 90
Neuropathic pain
Development of neuropathic pain via the DN-4 Patient interview questions
Time frame: Baseline and Day 30 and Day 90
Kidney function via the estimated glomerular filtration rate (eGRF)
Data will be gathered from routine examination, not a mandatory assessment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Department of Urology, University Hospital Freiburg
Freiburg im Breisgau, Germany
Universitätsklinik und Poliklinik für Urologie
Halle, Germany
Universitätsklinikum Heidelberg, Urologische Klinik
Heidelberg, Germany
Klinik für Urologie, Marien Hospital Herne
Herne, Germany
Department of Urology - Universitätsklinikum des Saarlandes
Homburg, Germany
Department of Urology, University Hospital Jena
Jena, Germany
Klinik für Urologie, Marien-Hospital Marl
Marl, Germany
...and 2 more locations
Time frame: Baseline until Day 5 / discharge (whatever is earlier)
Post operative complications
Any Clavien-Dindo I-V post-operative complication
Time frame: Day 90
Length of stay
Time from surgery to discharge
Time frame: Discharge
Procedure related readmissions
Readmission that can be linked to the partial nephrectomy
Time frame: Day 90
Procedure related reoperations
Re-operation that can be linked to the partial nephrectomy
Time frame: Day 90
Quality of recovery from the intervention
Quality of recovery questionnaire QoR-9
Time frame: Baseline until Day 5 / discharge (whatever is earlier)
Quality of life questionnaire, generic measure
EQ-5D 5L
Time frame: Baseline until Day 90
Quality of life questionnaire, cancer patient specific
EORTC QLQ-C30
Time frame: Baseline until Day 90
Overall survival
time from surgery to death from any cause
Time frame: Day of surgery to 5 years
Disease specific survival
time from surgery to death due to kidney cancer
Time frame: Day of surgery to 5 years
Disease free survival
time from surgery to first documented recurrence of renal cell carcinoma as defined by the investigator
Time frame: Day of surgery to 5 years
Local recurrence free survival
Time from surgery to the first documented local recurrence e.g. tumor in the operated kidney or in the immediate vicinity (e.g. perirenal fat) at the surgical site. Portside recurrence / incisional, surgical access site recurrence to the affected kidney would also be considered as a local recurrence.
Time frame: Day of surgery to 5 years
Comprehensive Complication Index
Any complication that occurred within 30 days post surgery
Time frame: Day of surgery to 30th post operative day